Citation Impact
Citing Papers
α4β3δ GABAAReceptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential
2001
Strategies to reduce the risk of drug‐induced QT interval prolongation: a pharmaceutical company perspective
2008
Imidazolones in Diastereoselective Cyclization Reactions and CuII‐Catalysed Cross‐Coupling Reactions
2009 StandoutNobel
Liquid-Phase Parallel Synthesis of Ureas
2001
Anandamide – the other side of the coin
2000 StandoutNobel
Glutamate-induced gamma oscillations in the dentate gyrus of rat hippocampal slices
2002
Characteristics of the Cholecystokinin-Induced Depolarization of Pacemaking Activity in Cultured Interstitial Cells of Cajal from Murine Small Intestine
2013 Standout
Cholecystokinin antagonists: Pharmacological and therapeutic potential
2003
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
2005 Standout
Ralph F. Hirschmann award address 2009: Merger of organic chemistry with peptide diversity
2010 StandoutNobel
Amino acid derived 1,4‐dialkyl substituted imidazolones
2010 StandoutNobel
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
2006 Standout
Catalytic asymmetric synthesis of the alkaloid (+)-myrtine
2008 StandoutNobel
Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic vascular beds
2005
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Sequential Functionalization of Pyrazole 1-Oxides via Regioselective Metalation: Synthesis of 3,4,5-Trisubstituted 1-Hydroxypyrazoles
2002
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Design and structure of a novel Neurokinin A receptor antagonist cyclo(-Met1-Asp2-Trp3-Phe4-Dap5-Leu6-)cyclo(2β-5β)
1995
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
2006
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
A Novel Rigid β-Turn Molecular Scaffold
1998
Diversity‐Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides
2017 StandoutNobel
Recent applications of the Suzuki–Miyaura cross-coupling reaction in organic synthesis
2002 Standout
A new synthesis of functionalized imidazol-2-ones
2000
Oxadiazoles in Medicinal Chemistry
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
A General Synthetic Method for the Formation of Substituted 5-Aminotetrazoles from Thioureas: A Strategy for Diversity Amplification
2000
β-Peptides: From Structure to Function
2001 Standout
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Gastrin induces CXC chemokine expression in gastric epithelial cells through activation of NF-κB
2001
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists
2017 StandoutNobel
Current and Novel Approaches to the Drug Treatment of Schizophrenia
2001
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Synthesis of 2-substituted piperazines via direct α-lithiation
2005
Palladium-Catalyzed Carbonylative Cross-Coupling with Imines: A Multicomponent Synthesis of Imidazolones
2007
Physiological roles and properties of potassium channels in arterial smooth muscle
1995 Standout
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats
2005 StandoutNobel
Isocyanates of Nα-[(9-Fluorenylmethyl)oxy]carbonyl Amino Acids: Synthesis, Isolation, Characterization, and Application to the Efficient Synthesis of Urea Peptidomimetics
2003
Synthesis and Structure–Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors
2015
Works of Alan E. Fletcher being referenced
Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors
1991
High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing Group
1994
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor
1998
Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility
1994
3-(1-Piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channels
1998
Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidAReceptors Determined Using36Cl Ion Flux
2001
Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists: N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas
1996
1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D4Receptor with Excellent Selectivity over Ion Channels
1999
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
1994
C5-piperazinyl-1,4-benzodiazepines, water-soluble, orally bioa vailable CCKB/gastrin receptor antagonists
1995